Market Place
Sourcing Support
All News #Library
Rare Diseases
Merck mulls PV program’s future while Takeda takes victory lap
08 Dec 2025 //
FIERCE BIOTECH
Takeda Drops Az-Partnered Neurological Program After Ph. 2 Fail
30 Oct 2025 //
FIERCE BIOTECH
Protagonist & Takeda`s ASCO Presentation on Ph 3 VERIFY Study
01 Jun 2025 //
BUSINESSWIRE
Takeda extends rare disease awareness campaign patient-inspired imagery, stories
08 Apr 2024 //
FIERCE PHARMA
Takeda wagers $300M on Protagonist’s PhIII rare disease drug
01 Feb 2024 //
ENDPTS
Takeda suffers setback as neuroscience prospect flunks phase 2
28 Jul 2023 //
FIERCE BIOTECH
Takeda to strengthen health system for rare diseases in India
19 May 2023 //
INDIAN PHARMA POST
CSL links drug to rare disease benefits, plans global filings
27 Feb 2023 //
FIERCE BIOTECH
Takeda highlights rare disease with `Number 17` campaign
28 Feb 2020 //
FIERCE PHARMA
Pharma-sponsored rare disease film festival doubles in size
21 Aug 2019 //
FIERCE PHARMA
Shire R&D chief Andy Busch jumps ship amid Takeda megamerger
09 Apr 2019 //
FIERCE BIOTECH
Takeda rare disease initiative launches diagnosis road map
28 Feb 2019 //
FIERC EPHARMA
Takeda announces +ve results from phase IIIb/IV trial for ADYNOVATE at EAHAD
08 Feb 2019 //
PHARMA BIZ
Shire`s drug for rare swelling disorder wins European panel green light
19 Oct 2018 //
REUTERS
FDA approves Shire drug for rare swelling disorder
23 Aug 2018 //
REUTERS
Recursion, Takeda Enter Rare Disease Discovery Partnership
11 Oct 2017 //
BIOCENTURY
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.